20.10
Schlusskurs vom Vortag:
$20.68
Offen:
$20.53
24-Stunden-Volumen:
308.44K
Relative Volume:
0.67
Marktkapitalisierung:
$1.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-85.21M
KGV:
-10.63
EPS:
-1.89
Netto-Cashflow:
$-68.53M
1W Leistung:
-0.05%
1M Leistung:
+0.70%
6M Leistung:
+16.93%
1J Leistung:
-27.57%
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Firmenname
Enliven Therapeutics Inc
Sektor
Branche
Telefon
720-647-8519
Adresse
6200 LOOKOUT ROAD, BOULDER
Vergleichen Sie ELVN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ELVN
Enliven Therapeutics Inc
|
20.10 | 1.22B | 0 | -85.21M | -68.53M | -1.89 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-16 | Eingeleitet | Goldman | Buy |
2024-12-13 | Eingeleitet | BTIG Research | Buy |
2024-09-09 | Eingeleitet | H.C. Wainwright | Buy |
2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
2024-04-09 | Eingeleitet | Mizuho | Buy |
2023-03-29 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Enliven Therapeutics Inc. recovery potential after sell offBuy Signal & Safe Capital Growth Plans - newser.com
What the charts say about Enliven Therapeutics Inc. todayShort Setup & Daily Volume Surge Trade Alerts - newser.com
How to read the order book for Enliven Therapeutics Inc.July 2025 Setups & AI Forecast Swing Trade Picks - newser.com
Strategies to average down on Enliven Therapeutics Inc.July 2025 Patterns & Expert Curated Trade Setups - newser.com
Heatmap analysis for Enliven Therapeutics Inc. and competitorsJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Trade Exit Summary & Consistent Return Investment Signals - newser.com
Chart based exit strategy for Enliven Therapeutics Inc.July 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Trading 6.1% HigherHere's Why - MarketBeat
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat
Volatility clustering patterns for Enliven Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - newser.com
Is a relief rally coming for Enliven Therapeutics Inc. holdersWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Long term hold vs stop loss in Enliven Therapeutics Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Using Ichimoku Cloud for Enliven Therapeutics Inc. technicals2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Enliven Therapeutics COO Patel sells $133,992 in stock By Investing.com - Investing.com South Africa
Enliven Therapeutics COO Patel sells $133,992 in stock - Investing.com
Short interest data insights for Enliven Therapeutics Inc.Market Activity Report & Real-Time Volume Spike Alerts - newser.com
What moving averages say about Enliven Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - newser.com
Why retail investors favor Enliven Therapeutics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is now a turning point for Enliven Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com
Enliven Therapeutics stock falls after pricing capital raise of $200M via securities offering - MSN
Developing predictive dashboards with Enliven Therapeutics Inc. dataStop Loss & Weekly Sector Rotation Insights - newser.com
Will Enliven Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
Top chart patterns to watch in Enliven Therapeutics Inc.July 2025 Retail & Risk Managed Investment Signals - newser.com
Will Enliven Therapeutics Inc. stock recover after recent drop2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Benjamin Hohl Sells 3,250 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $81,000.00 in Stock - MarketBeat
Enliven Therapeutics CFO sells $22,524 in stock - MSN
Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 3,700 Shares - MarketBeat
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Enliven Therapeutics Inc-Aktie (ELVN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Sep 29 '25 |
Option Exercise |
2.48 |
3,250 |
8,060 |
26,250 |
Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Sep 29 '25 |
Sale |
20.40 |
3,250 |
66,291 |
23,000 |
Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Sep 26 '25 |
Sale |
20.25 |
4,000 |
81,005 |
927,688 |
Kintz Samuel | PRESIDENT AND CEO |
Sep 26 '25 |
Sale |
20.06 |
3,700 |
74,228 |
915,392 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):